Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on EMvision Medical Devices.
RELATED STOCKHEAD STORIES
Director Trades
Directors’ Trades: It is ever too late to jump on the bandwagon?
IPO Watch
2018 ASX IPOs are doing much better two years on
Health & Biotech
Factor Therapeutics may finally have found its future — in veterinary imaging
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Will EMVision’s links to Nanosonics set it up for similar success?
Health & Biotech
Medtech needs more than a TGA tick to hit the big $$$
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Noxopharm wants to test its anti-prostate cancer drug against COVID-19
Health & Biotech
Cann pulls back from Mildura pot project as world flooded with weed
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: EMVision has built its portable brain scanner, trial to begin imminently
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Great day for Paradigm as knee data drops and $78m cap raise opens
IPO Watch
IPO Watch: Gold explorer Yandal next up to hit the ASX, but it may be a slow start
IPO Watch
